RegenHeart: A Time-Effective, Low-Concentration, Detergent-Based Method Aiming for Conservative Decellularization of

Eleonora Dal Sasso1, Roberta Menabò2,3, Davide Agrillo1

  • 1Cardiovascular Regenerative Medicine, Department of Cardiac Thoracic Vascular Sciences and Public Health, University of Padua, Padua 35128, Italy.

Insights

A new method efficiently decellularizes rat hearts, preserving extracellular matrix structure and bioactivity. This technique offers a promising path toward creating biocompatible cardiac tissue for heart failure patients, avoiding immunosuppression.

Area of Science:

  • Regenerative Medicine
  • Cardiovascular Research
  • Biomaterials Science

Background:

  • Heart failure is a leading cause of mortality with limited effective treatments.
  • Current solutions like allogeneic heart transplantation face challenges including immunosuppression side effects and donor scarcity.
  • Autologous cell-based biological cardiac substitutes from decellularized organs offer a potential lifelong, biocompatible solution.

Purpose of the Study:

  • To develop and test a novel, rapid decellularization method for rat hearts.
  • To minimize cytotoxic detergent exposure while preserving the cardiac extracellular matrix (ECM) architecture and bioactivity.

Main Methods:

  • A new decellularization protocol using protease inhibition, antioxidation, and excitation-contraction uncoupling.
  • Simultaneous perfusion/submersion modality to reduce detergent concentration and incubation time.
  • Assessment of ECM preservation, macro- and microarchitecture, and bioactivity in decellularized rat hearts.

Main Results:

  • The novel method significantly reduced detergent exposure time and concentration.
  • Decellularized hearts exhibited well-preserved ECM macro- and microarchitecture.
  • The decellularization process maintained the inherent bioactivity of the cardiac scaffold.

Conclusions:

  • This innovative decellularization technique effectively preserves cardiac ECM integrity and bioactivity.
  • The method represents a significant advancement for creating biological cardiac substitutes.
  • It holds promise for developing advanced regenerative therapies for heart failure, potentially eliminating the need for immunosuppression.

Related Concept Videos